Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, and Colorectal Cancer Treatments and Studies.
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.
Abstract CT112: Initial results from a Phase 1 trial of a first-in-class pan-CDC-like kinase inhibitor (SM08502) with proof of mechanism in subjects with advanced solid tumors
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
The innate responses of bumble bees to flower patterns: separating the nectar guide from the nectary changes bee movements and search time
A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer